Sotera Health (NASDAQ:SHC) Sees Large Volume Increase – Time to Buy?

Shares of Sotera Health (NASDAQ:SHC) saw unusually-strong trading volume on Tuesday . Approximately 1,561,190 shares changed hands during trading, an increase of 33% from the previous session’s volume of 1,171,206 shares.The stock last traded at $11.36 and had previously closed at $11.66.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. Barclays reduced their price objective on shares of Sotera Health from $17.00 to $16.00 and set an “overweight” rating on the stock in a research note on Friday, February 28th. The Goldman Sachs Group started coverage on shares of Sotera Health in a research report on Friday, December 6th. They issued a “neutral” rating and a $14.00 price objective for the company. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $16.00.

Sotera Health Stock Performance

The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. The stock has a market capitalization of $3.16 billion, a P/E ratio of 44.62 and a beta of 1.92. The company has a 50-day moving average price of $12.82 and a two-hundred day moving average price of $13.95.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Geode Capital Management LLC raised its position in shares of Sotera Health by 19.4% during the 3rd quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company’s stock valued at $46,026,000 after buying an additional 447,186 shares in the last quarter. Maven Securities LTD purchased a new stake in Sotera Health in the 3rd quarter worth approximately $1,670,000. Cerity Partners LLC purchased a new stake in Sotera Health in the third quarter worth $1,489,000. Neo Ivy Capital Management purchased a new position in shares of Sotera Health during the third quarter valued at approximately $720,000. Finally, Barclays PLC boosted its position in shares of Sotera Health by 169.8% in the 3rd quarter. Barclays PLC now owns 473,597 shares of the company’s stock worth $7,909,000 after purchasing an additional 298,085 shares in the last quarter. Institutional investors own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.